PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure
In this retrospective cohort study, the PREVENT model underestimated risk in patients not treated with statins, whereas the PCE estimates more closely reflected what a patient's risk would be without statin therapy.
Authors
- Wansu Chen (ORCID: https://orcid.org/0000-0002-3486-7468)
- Yi‐Lin Wu (ORCID: https://orcid.org/0000-0003-3758-3177)
- James Onwuzurike
- Darryl E. Palmer‐Toy (ORCID: https://orcid.org/0000-0003-3318-0506)
- Ming‐Sum Lee (ORCID: https://orcid.org/0000-0001-6121-6452)
- Jaejin An
Institutions
- Kaiser Permanente (US)
- Los Angeles Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.32164
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Kaiser Permanente
- National Institutes of Health